Assistant Professor, Pathology-Brigham and Women's Hospital, Harvard Medical School
Pathology
Dr. Lynette M. Sholl, MD
|
|
Give Review
Lynette Sholl practices Pathology. She studied medicine at Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care Lynette M. Sholl has written publications. She has 45 publications published with PubMed. The lastest publication is: ''Inflammatory myofibroblastic tumor'-like dedifferentiation of ALK-rearranged lung adenocarcinoma.' Lynette M. Sholl, MD is registered with Medicare.
Publications
- Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.
- Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes.
- Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: The Lung Cancer Mutation Consortium experience.
- Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors.
- Myc Protein Expression Correlates With MYC Amplification In Small Cell Lung Carcinoma.
- BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers.
- Pulmonary Pathology: SC22-1 EGFR TESTING IN LUNG CARCINOMA: PAST, PRESENT AND FUTURE.
- Biomarkers in Lung Adenocarcinoma: A Decade of Progress.
- Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC.
- Novel Genetic Mutations in a Sporadic Port-Wine Stain.
- Filter Paper-based Nucleic Acid Storage in High-throughput Solid Tumor Genotyping.
- Targeted Genomic Analysis of Müllerian Adenosarcoma.
- Prospective Enterprise-Level Molecular Genotyping of a Cohort of Cancer Patients.
- Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors.
- Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis.
- Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
- Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma.
- Large-cell carcinoma of the lung: a diagnostic category redefined by immunohistochemistry and genomics.
- Intrathymic cyst: Clinical and radiological features in surgically resected cases.
- Treatment-related toxicities in a phase II trial of dasatinib in patients with squamous cell carcinoma of the lung.
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors.
- Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma.
- Template for Reporting Results of Biomarker Testing of Specimens From Patients With Non-Small Cell Carcinoma of the Lung.
- Adam8 limits the development of allergic airway inflammation in mice.
- Molecular Alterations in Partially-Encapsulated/Well-Circumscribed Follicular Variant of Papillary Thyroid Carcinoma.
- Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK-Rearranged Lung Adenocarcinomas.
- Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab.
- TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis.
- Molecular analysis of gene rearrangements and mutations in acute leukemias and myeloproliferative neoplasms.
- Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma.
- Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis.
- EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry.
- Molecular analysis of genetic markers for non-Hodgkin lymphomas.
- Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
- Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.
- Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.
- In situ genetic analysis of cellular chimerism.
- Clinical JAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations.
- Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma.
- Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases.
- Ewing sarcoma mimicking atypical carcinoid tumor: detection of unexpected genomic alterations demonstrates the use of next generation sequencing as a diagnostic tool.
- Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
- 'Inflammatory myofibroblastic tumor'-like dedifferentiation of ALK-rearranged lung adenocarcinoma.
- KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Schools
Stanford University
Hospital Of University Of Penn
Brigham and Women39s Hospital
Doctors Specialties
- Molecular Genetic Pathology
- Pathology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
University of Pennsylvania Health System -
Stanford University School of Medicine
Hospital
-
Brigham and Women's Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417015017 |
| Last Name Of The Provider | SHOLL |
| First Name Of The Provider | LYNETTE |
| View All |
Similar Doctors
|
|
Dr. Eveline E. Schneeberger, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Matija Snuderl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valentina Nardi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danny A. Milner Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janina A. Longtine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neal I. Lindeman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Andrew H. Beck, MD
This Doctor is OpenDoctor Recommended.
|